GLP-1 medications are reshaping obesity care, but their potential impact may extend well beyond weight loss. In this episode of Mental Health Pathfinders, host Erin Connors speaks with Charles Nemeroff, M.D., about what psychiatrists should know about GLP-1 medications, from addressing weight gain and metabolic risks associated with psychiatric treatment to emerging research on cravings, alcohol use disorder, and other addictive behaviors. They also discuss potential psychiatric effects, safety considerations, and concerns about inappropriate use as these medications become increasingly common.